NCT04656431
- Conditions
- Primary CNS Lymphoma
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
Primary CNS Lymphoma
Explore clinical trials studying Primary CNS Lymphoma. Study availability and eligibility vary by location and protocol.
9 public trials
5 recruiting studies
Primary CNS Lymphoma trial results
Recruiting
Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.
NCT04627753
- Conditions
- Primary CNS Lymphoma
- Locations
-
- Samsung Medical Center Seoul, South Korea
Recruiting
Diagnosis; Objective RespOnse; THErApy
NCT05036564
- Conditions
- Primary CNS Lymphoma
- Locations
-
- IRCCS Ospedale San Raffaele Milan, Italy/Lombardy, Italy
NCT04006561
- Conditions
- Brain Lymphoma, Chemically-Induced Disorders, Nervous System Diseases, +3 more
- Locations
-
- Chang Gung Memorial Hospital Taoyuan, Taiwan
NCT05518383
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +19 more
- Locations
-
- Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, RF, Russia
Completed
Tisagenlecleucel In Primary CNS Lymphoma
NCT04134117
- Conditions
- Primary CNS Lymphoma, Refractory Primary CNS Lymphoma, Relapsed Primary CNS Lymphoma
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
NCT04947319
- Conditions
- Primary CNS Lymphoma, Refractory Primary Central Nervous System Lymphoma
- Locations
-
- University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
- Mayo Clinic- Phoenix Phoenix, Arizona, United States
- City of Hope Comprehensive Breast Cancer Center Duarte, California, United States
- University of California, Irvine Irvine, California, United States
Active, Not Recruiting
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
NCT04464200
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States
Active, Not Recruiting
Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma
NCT04443829
- Conditions
- Primary CNS Lymphoma
- Locations
-
- University College London Hospital London, United Kingdom